Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000210047 | SCV001522230 | pathogenic | Nephrotic syndrome, type 2 | 2019-11-15 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Center for Genomic Medicine, |
RCV000210047 | SCV004807939 | uncertain significance | Nephrotic syndrome, type 2 | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Human Genetics Disease in Children – Taif University, |
RCV000210047 | SCV000265972 | pathogenic | Nephrotic syndrome, type 2 | 2016-01-01 | no assertion criteria provided | clinical testing | |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000210047 | SCV001192766 | pathogenic | Nephrotic syndrome, type 2 | 2019-08-07 | no assertion criteria provided | clinical testing |